Watchlist Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

12.87

-0.47 (-3.52%)

At close: Jun 06, 2025, 3:59 PM

12.59

-2.18%

After-hours: Jun 06, 2025, 05:57 PM EDT

Maze Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-32.79M	-29.58M	-24.75M	-26.58M	-24.75M
Depreciation & Amortization	684K	705K	788K	976K	1M
Stock-Based Compensation	3.23M	2.85M	2.34M	2.56M	2.11M
Other Working Capital	n/a	210K	-4.06M	-2.22M	206K
Other Non-Cash Items	n/a	2.54M	3.65M	4.65M	695K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	1.03M	-5.23M	-2.25M	963K
Operating Cash Flow	-29.52M	-22.45M	-23.2M	-20.64M	-19.97M
Capital Expenditures	-299K	-605K	-103K	-34K	3K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-299K	-605K	-103K	-34K	3K
Debt Repayment	n/a	n/a	n/a	16.18M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	127.38M	70.26M	-2.15M	12K	8K
Financial Cash Flow	127.38M	70.26M	-2.15M	16.19M	8K
Net Cash Flow	97.56M	47.2M	-25.46M	-4.49M	-19.96M
Free Cash Flow	-29.82M	-23.06M	-23.31M	-20.68M	-19.97M